{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:22:55Z","timestamp":1790839375384,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.imbio.2005.10.006","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T07:13:38Z","timestamp":1129878818000},"page":"755-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Predictive role of hs-C-reactive protein in patients with antiphospholipid syndrome"],"prefix":"10.1016","volume":"210","author":[{"given":"Wolfgang","family":"Miesbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buket","family":"G\u00f6kpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gilzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Claus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Scharrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2005.10.006_bib1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/01.CIR.99.7.855","article-title":"Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability","volume":"99","author":"Biasucci","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.imbio.2005.10.006_bib2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.imbio.2005.10.006_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0038-1653808","article-title":"Comparison of the effect of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation","volume":"73","author":"Campbell","year":"1995","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.imbio.2005.10.006_bib4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","article-title":"C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor","volume":"82","author":"Cermak","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2005.10.006_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1191\/096120399678847524","article-title":"Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes","volume":"8","author":"Chapman","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.imbio.2005.10.006_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses","volume":"321","author":"Danesh","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.imbio.2005.10.006_bib7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2005.10.006_bib8","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biological basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2005.10.006_bib9","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/1529-0131(200111)44:11<2467::AID-ART426>3.0.CO;2-U","article-title":"The role of tissue factor in the antiphospholipid syndrome","volume":"44","author":"Dobado-Berrios","year":"2001","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.imbio.2005.10.006_bib10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/41.8.924","article-title":"A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome","volume":"41","author":"Erkan","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.imbio.2005.10.006_bib11","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2005.10.006_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1191\/0961203302lu202cr","article-title":"Revisiting the anticardiolipin test and its standardization","volume":"11","author":"Harris","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.imbio.2005.10.006_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410380119","article-title":"Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome","volume":"38","author":"Levine","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.imbio.2005.10.006_bib14","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.STR.28.9.1660","article-title":"IgG anticardiolipin antibody titer>40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study","volume":"28","author":"Levine","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.imbio.2005.10.006_bib15","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease","volume":"343","author":"Lindahl","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2005.10.006_bib16","series-title":"Hughes Syndrome. Antiphospholipid Syndrome","first-page":"214","article-title":"Lupus anticoagulant measurement","author":"Mackie","year":"2000"},{"key":"10.1016\/j.imbio.2005.10.006_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/jaut.2000.0412","article-title":"Endothelial activation by aPL. A potential pathogenetic mechanism for the clinical manifestations of the syndrome","volume":"15","author":"Meroni","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imbio.2005.10.006_bib18","doi-asserted-by":"crossref","unstructured":"Miesbach, W., Gilzinger, A., G\u00f6kpinar, B., Claus, D., Scharrer, I., 2005. Prevalence of antiphospholipid antibodies in patients with neurological symptoms. Clin. Neurol. Neurosurg, in press. doi:10.1016\/j.clineuro.2005.03.005","DOI":"10.1016\/j.clineuro.2005.03.005"},{"key":"10.1016\/j.imbio.2005.10.006_bib19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1538-7836.2004.00792.x","article-title":"The utility of C-reactive protein in the detection of atherothrombotic vascular disease: ready for prime time","volume":"2","author":"Mohan","year":"2004","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.imbio.2005.10.006_bib20","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.imbio.2005.10.006_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.imbio.2005.10.006_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00001573-200207000-00001","article-title":"High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease","volume":"17","author":"Rosenson","year":"2002","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.imbio.2005.10.006_bib23","doi-asserted-by":"crossref","first-page":"10i","DOI":"10.1016\/S0002-9149(03)00504-6","article-title":"Utility of inflammatory markers in the management of coronary artery disease","volume":"92","author":"Rosenson","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.imbio.2005.10.006_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000048623","article-title":"Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study","volume":"21","author":"Tanne","year":"2002","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.imbio.2005.10.006_bib25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood.V68.4.869.869","article-title":"The use of the dilute Russel viper venome time for the diagnosis of lupus anticoagulants","volume":"68","author":"Thiagarajan","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2005.10.006_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1055\/s-0038-1649701","article-title":"The Textarin\/Ecarin ratio: a confirmatory test for lupus anticoagulants","volume":"70","author":"Triplett","year":"1993","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.imbio.2005.10.006_bib27","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imbio.2005.10.006_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.atherosclerosis.2004.05.022","article-title":"C-reactive gene polymorphisms and the incidence of post-angioplasty restenosis","volume":"176","author":"Zee","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.imbio.2005.10.006_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1172\/JCI119572","article-title":"Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies","volume":"100","author":"Ziporen","year":"1997","journal-title":"J. Clin. Invest."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298505001440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298505001440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:20:49Z","timestamp":1759249249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298505001440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0171298505001440"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2005.10.006","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive role of hs-C-reactive protein in patients with antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2005.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}